HLB Life Science Co., Ltd. (067630.KQ)
KRW 9780.0
(-1.81%)
KRW 9780.0
(-1.81%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 423.5 Billion KRW | 2.84% |
| 2022 | 411.79 Billion KRW | 52.06% |
| 2021 | 270.79 Billion KRW | -17.24% |
| 2020 | 327.19 Billion KRW | -19.2% |
| 2019 | 404.93 Billion KRW | 9.11% |
| 2018 | 371.13 Billion KRW | 274.81% |
| 2017 | 99.01 Billion KRW | 19.76% |
| 2016 | 82.67 Billion KRW | 93.63% |
| 2015 | 42.69 Billion KRW | 27.86% |
| 2014 | 33.39 Billion KRW | -30.75% |
| 2013 | 48.22 Billion KRW | 5.14% |
| 2012 | 45.86 Billion KRW | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 629.55 Billion KRW | 48.65% |
| 2024 Q2 | 493.65 Billion KRW | -21.59% |
| 2023 Q1 | 426.71 Billion KRW | 3.62% |
| 2023 Q3 | 414.43 Billion KRW | 0.04% |
| 2023 Q4 | 423.5 Billion KRW | 2.19% |
| 2023 FY | 423.5 Billion KRW | 2.84% |
| 2023 Q2 | 414.26 Billion KRW | -2.92% |
| 2022 Q3 | 484.72 Billion KRW | 31.92% |
| 2022 FY | 411.79 Billion KRW | 52.06% |
| 2022 Q4 | 411.79 Billion KRW | -15.05% |
| 2022 Q2 | 367.43 Billion KRW | 43.77% |
| 2022 Q1 | 255.57 Billion KRW | -5.62% |
| 2021 Q4 | 270.79 Billion KRW | -18.7% |
| 2021 Q3 | 333.1 Billion KRW | 12.55% |
| 2021 FY | 270.79 Billion KRW | -17.24% |
| 2021 Q1 | 308.18 Billion KRW | -5.81% |
| 2021 Q2 | 295.94 Billion KRW | -3.97% |
| 2020 Q3 | 364.97 Billion KRW | -2.7% |
| 2020 Q4 | 327.19 Billion KRW | -10.35% |
| 2020 Q1 | 379.52 Billion KRW | -6.27% |
| 2020 Q2 | 375.1 Billion KRW | -1.16% |
| 2020 FY | 327.19 Billion KRW | -19.2% |
| 2019 Q1 | 387.26 Billion KRW | 4.35% |
| 2019 FY | 404.93 Billion KRW | 9.11% |
| 2019 Q4 | 404.93 Billion KRW | 14.19% |
| 2019 Q3 | 354.6 Billion KRW | -18.13% |
| 2019 Q2 | 433.12 Billion KRW | 11.84% |
| 2018 Q4 | 371.13 Billion KRW | 62.54% |
| 2018 FY | 371.13 Billion KRW | 274.81% |
| 2018 Q3 | 228.32 Billion KRW | 16.94% |
| 2018 Q2 | 195.24 Billion KRW | -0.61% |
| 2018 Q1 | 196.43 Billion KRW | 98.39% |
| 2017 Q1 | 81.64 Billion KRW | -1.25% |
| 2017 Q2 | 82.96 Billion KRW | 1.61% |
| 2017 Q3 | 85.4 Billion KRW | 2.95% |
| 2017 Q4 | 99.01 Billion KRW | 15.94% |
| 2017 FY | 99.01 Billion KRW | 19.76% |
| 2016 Q4 | 82.67 Billion KRW | 3.71% |
| 2016 FY | 82.67 Billion KRW | 93.63% |
| 2016 Q3 | 79.72 Billion KRW | 107.45% |
| 2016 Q2 | 38.42 Billion KRW | -4.74% |
| 2016 Q1 | 40.34 Billion KRW | -5.52% |
| 2015 Q2 | 30.86 Billion KRW | -4.79% |
| 2015 Q1 | 32.41 Billion KRW | -2.94% |
| 2015 FY | 42.69 Billion KRW | 27.86% |
| 2015 Q3 | 28.83 Billion KRW | -6.58% |
| 2015 Q4 | 42.69 Billion KRW | 48.1% |
| 2014 Q1 | 37.41 Billion KRW | -22.41% |
| 2014 Q4 | 33.39 Billion KRW | -13.55% |
| 2014 FY | 33.39 Billion KRW | -30.75% |
| 2014 Q3 | 38.62 Billion KRW | -10.75% |
| 2014 Q2 | 43.28 Billion KRW | 15.66% |
| 2013 Q2 | 43.82 Billion KRW | 0.38% |
| 2013 Q3 | 47.11 Billion KRW | 7.5% |
| 2013 Q4 | 48.22 Billion KRW | 2.36% |
| 2013 FY | 48.22 Billion KRW | 5.14% |
| 2013 Q1 | 43.66 Billion KRW | -4.81% |
| 2012 FY | 45.86 Billion KRW | 0.0% |
| 2012 Q3 | 52.36 Billion KRW | 0.0% |
| 2012 Q4 | 45.86 Billion KRW | -12.41% |
| Name | Total Assets | Total Assets Difference |
|---|